Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study
Clinical trial NCT02760056 · COMPLETED
Trial details
- NCT number
- NCT02760056
- Sponsor
- Oregon Health and Science University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-06
- Primary completion
- 2017-01-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.